2275 related articles for article (PubMed ID: 7868768)
21. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness.
Morton DL; Davtyan DG; Wanek LA; Foshag LJ; Cochran AJ
Cancer; 1993 Jun; 71(11):3737-43. PubMed ID: 8490924
[TBL] [Abstract][Full Text] [Related]
22. Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome.
Stidham KR; Johnson JL; Seigler HF
Arch Surg; 1994 Mar; 129(3):316-24. PubMed ID: 7848393
[TBL] [Abstract][Full Text] [Related]
23. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.
Kujala E; Kivelä T
Ophthalmology; 2005 Jun; 112(6):1135-44. PubMed ID: 15885792
[TBL] [Abstract][Full Text] [Related]
24. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
[TBL] [Abstract][Full Text] [Related]
25. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
[TBL] [Abstract][Full Text] [Related]
26. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients.
Drepper H; Köhler CO; Bastian B; Breuninger H; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
Cancer; 1993 Aug; 72(3):741-9. PubMed ID: 8334626
[TBL] [Abstract][Full Text] [Related]
27. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.
Ben-Porat L; Panageas KS; Hanlon C; Patel A; Halpern A; Houghton AN; Coit D
Cancer; 2006 Jan; 106(1):163-71. PubMed ID: 16331596
[TBL] [Abstract][Full Text] [Related]
28. Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow).
Wanebo HJ; Fortner JG; Woodruff J; MacLean B; Binkowski E
Ann Surg; 1975 Sep; 182(3):302-15. PubMed ID: 1164058
[TBL] [Abstract][Full Text] [Related]
29. Clinical, histological and quantitative prognostic factors in cutaneous malignant melanoma.
Karjalainen J; Eskelinen M; Kosma VM; Lipponen P; Tuominen L; Alhava E
Anticancer Res; 1992; 12(5):1507-11. PubMed ID: 1444213
[TBL] [Abstract][Full Text] [Related]
30. Serum angiogenin levels predict treatment response in patients with stage IV melanoma.
Vihinen P; Kallioinen M; Vuoristo MS; Ivaska J; Syrjänen KJ; Hahka-Kemppinen M; Kellokumpu-Lehtinen PL; Pyrhönen SO
Clin Exp Metastasis; 2007; 24(7):567-74. PubMed ID: 17762972
[TBL] [Abstract][Full Text] [Related]
31. [TNM classification of malignant melanoma and non-melanoma skin cancer].
Suzuki T; Inoue Y; Kiyohara Y; Ikeda S
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2163-9. PubMed ID: 9388531
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma.
Yoshino Y; Kageshita T; Nakajima M; Funakubo M; Ihn H
J Dermatol; 2008 Apr; 35(4):206-14. PubMed ID: 18419677
[TBL] [Abstract][Full Text] [Related]
33. The value of current staging systems for melanoma of the extremities.
Ghussen F; Krüger I; Groth W
Cancer; 1990 Jul; 66(2):396-401. PubMed ID: 2369720
[TBL] [Abstract][Full Text] [Related]
34. Classification of localized melanoma by the exponential survival trees method.
Huang X; Soong S; McCarthy WH; Urist MM; Balch CM
Cancer; 1997 Mar; 79(6):1122-8. PubMed ID: 9070489
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma.
Law MM; Wong JH
Am Surg; 1994 May; 60(5):362-6. PubMed ID: 8161088
[TBL] [Abstract][Full Text] [Related]
36. [Cutaneous melanomas in old patients. Prognostic factors and actuarial survival].
Ortolani C; Paz RA
Medicina (B Aires); 1992; 52(1):23-9. PubMed ID: 1302287
[TBL] [Abstract][Full Text] [Related]
37. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
38. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
39. Basal neutrophil-to-lymphocyte ratio is associated with overall survival in melanoma.
Lino-Silva LS; Salcedo-Hernández RA; García-Pérez L; Meneses-García A; Zepeda-Najar C
Melanoma Res; 2017 Apr; 27(2):140-144. PubMed ID: 28125448
[TBL] [Abstract][Full Text] [Related]
40. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
